Stock TYRA TYRA BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Tyra Biosciences, Inc.

Equities

TYRA

US90240B1061

Market Closed - Nasdaq
Other stock markets
 21:00:00 17/05/2024 BST 		5-day change 1st Jan Change
18.26 USD -4.40% Intraday chart for Tyra Biosciences, Inc. +5.24% +31.84%
05-13 Oppenheimer Adjusts Tyra Biosciences Price Target to $28 From $25, Maintains Outperform Rating MT
05-09 Tyra Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Tyra Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Tyra Biosciences, Inc. Announces Board Changes
Tyra Biosciences Q4 Net Loss Widens
Tyra Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Tyra Biosciences, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
Sector Update: Health Care Stocks Advance Late Afternoon
Sector Update: Health Care
Tyra Biosciences Launches $200 Million Private Placement; Shares Rise
Top Midday Gainers
Tyra Biosciences Launches $200 Million Private Placement; Shares Rise
Tyra Biosciences Receives FDA Rare Pediatric Disease Designation for Potential Achondroplasia Treatment
Tyra Biosciences, Inc. Receives FDA Rare Pediatric Disease Designation for TYRA-300 for the Treatment of Achondroplasia
Tyra Biosciences, Inc. Doses First Patient with TYRA-200 and Provides Positive Updates on TYRA-300
Tyra Biosciences Doses 1st Patient in Phase 1 Liver Cancer Treatment Trial
Tyra Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Tyra Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Tyra Biosciences Announces Fda Orphan Drug Designation for Tyra-300 for the Treatment of Achondroplasia
Insider Sell: Tyra Biosciences
Insider Sell: Tyra Biosciences
Insider Sell: Tyra Biosciences
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TYRA Stock
  4. News Tyra Biosciences, Inc.
  5. Other languages